Viewing StudyNCT00299702



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00299702
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2006-03-03

Brief Title: Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-year Period in Patients With Schizophrenia
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-02
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2006-03-03
First Submit QC Date: March 3 2006
Study First Post Date: 2006-03-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2010-03-16
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-12-22
Last Update Post Date: 2011-12-30
Last Update Post Date Type: ESTIMATED